GMO warns AI is a 'classic investment bubble.' Here's what to buy instead.

In its Nov. 21 quarterly letter, GMO (led by Ben Inker and associated with Jeremy Grantham) warns that AI-related stocks show classic bubble characteristics—very high valuations and rampant speculation—citing quantum computing names up roughly 1,200% over the past year and valuations that make Palantir look like a value stock. GMO likens the backdrop most closely to the dot‑com era but argues investors need not wholesale de‑risk portfolios; instead it recommends tilts into developed-market value and non‑U.S. small‑cap value (notably Japan), pointing to ETFs such as Avantis International Small Cap Value (AVDV) and iShares MSCI Intl Value Factor (IVLU) as implementations.

Analysis

Market structure: The obvious winners while AI enthusiasm persists are mega-cap AI plays and speculative “quantum/AI” small caps (momentum-driven flow beneficiaries); losers are cyclicals and value names that have become under-allocated. Elevated prices imply lower marginal buyers and much higher sensitivity to negative news — implied vol and skew on large-cap tech and thematic funds should rise; dollar-strength and Treasury demand could pick up if risk-off flows accelerate, pressuring EM and commodity-linked names.

Risk assessment: Tail risks include a rapid re-pricing event driven by disappointing AI revenue proofs or regulatory action (high-impact, 1–3 month horizon) and a slower capex pullback if ROI on AI projects misses expectations (6–24 months). Hidden dependencies: many AI valuations assume accelerating top-line growth and gross-margin expansion; if enterprise adoption lags, revisions will cascade through multiples. Catalysts to monitor: quarterly cloud/AI guidance, large model capex announcements, and major antitrust or export-rule headlines — watch earnings windows (next 30–90 days).

Trade implications: Favor valuation-sensitive reallocation into developed-market value and non-US small-cap value (e.g., AVDV, IVLU, Japan small-cap value) over AI momentum. Implement pair trades: long IVLU/AVDV vs short QQQ or thematic ETFs to express a shift away from AI without net market exposure. Use options: small hedge sized 0.5–1% of AUM via 3–6 month put spreads on ARKK/SOXL or buy a VIX 1–2 point call spread to protect 1–3 month downside.

Contrarian angles: Consensus treats AI as a permanent structural re-rate; that ignores mean-reversion in sentiment and the capital-intensity/time-to-profit gap for many names. The dot‑com parallel is apt but not identical — select winners with durable cashflows (enterprise software with sticky ARR) may still re-rate higher; avoid blanket shorts and prefer relative-value trades and volatility hedges.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Avantis International Small Cap Value ETF (AVDV) or iShares MSCI Intl Value Factor ETF (IVLU) within the next 2 weeks; scale to 4% over 3 months if trailing 3-month excess return vs MSCI ACWI > +2%; initial stop-loss at -12% from entry.
• Implement a pair trade: long 3% AVDV (or IVLU) and short 3% QQQ (or ARKK) to express rotation away from AI momentum; hold 3–12 months and unwind if AI leaders underperform value by >10% or outperform by >10% for two consecutive months.
• Purchase asymmetric protection: allocate 0.5–1% of portfolio to 3–6 month put spreads on ARKK or SOXL (10–25% OTM depending on cost) or a VIX call spread to cap downside if a volatility spike occurs during upcoming earnings windows (next 30–90 days).
• Reduce US mega-cap growth exposure by 20–30% of current weight over 6–12 months and redeploy proceeds into non-US small-cap value (Japan small-cap value prioritized); trigger accelerated rebalancing if top AI names decline >20% from current highs within 60 days.